共 23 条
- [21] Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Against Rheumatism: Analysis Based on Patient Reported Outcomes Analyzed from 3 Phase III Golimumab Clinical Trials of Golimumab [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 968 - 969
- [22] VALIDATION OF REMISSION OF RHEUMATOID ARTHRITIS BY TRADITIONAL DISEASE ACTIVITY SCORE AND PROVISIONAL CRITERIA BY AMERICAN COLLEGE OF RHEUMATOLOGY AND EUROPEAN LEAGUE AGAINST RHEUMATISM: ANALYSIS BASED ON PATIENT-REPORTED OUTCOMES ANALYSED FROM THREE PHASE III GOLIMUMAB CLINICAL TRIALS [J]. RHEUMATOLOGY, 2013, 52 : 83 - 83
- [23] A pooled index of patient questionnaire data discriminates between responses to leflunomide (LEF) or methotrexate (MTX) vs placebo at a 20% level as effectively as the disease activity index (DAS), ACR20, pooled index of non-patient questionnaire measures or all 7 core data set measures in a clinical trial of patients with rheumatoid arthritis (RA). [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S186 - S186